Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(9):653; doi:10.1093/jnci/96.9.653
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Zielinski, S. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Zielinski, S. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

NEWS

In Brief

Sarah L. Zielinski

The first 10% of the full text of this article appears below.

Genetic Testing Helps Breast Cancer Patients Make Surgery Decisions

Testing women newly diagnosed with breast cancer for the genetic mutations that are associated with an increased risk of the disease affects the decisions they make about treatment, according to a new study.

Breast cancer patients with BRCA1 or BRCA2 gene mutations are up to 60% more likely to develop cancer in the opposite breast, known as contralateral breast cancer, for at least 10 years after . . . [Full Text of this Article]

Survival after Colorectal Cancer Keyhole Surgery Same as that for Conventional Surgery

Scientists Develop Tool to Predict Cancer Survival from Gene Expression


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?